| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 4.46M | £ 4.11M | £ 2.19M | £ 2.18M | £ 1.63M |
| Gross Profit | £ 3.06M | £ 3.17M | £ 1.72M | £ 1.43M | £ 1.04M |
| Operating Income | £ -826.67K | £ -989.00K | £ -1.94M | £ -2.31M | £ -2.35M |
| EBITDA | £ -383.33K | £ 401.00K | £ -1.57M | £ -1.95M | £ -2.04M |
| Net Income | £ -145.33K | £ 1.00K | £ -1.44M | £ -2.00M | £ -2.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 3.25M | £ 3.57M | £ 3.93M | £ 1.48M | £ 2.96M |
| Total Assets | £ 9.12M | £ 9.26M | £ 8.17M | £ 5.66M | £ 7.63M |
| Total Debt | £ 794.00K | £ 1.03M | £ 389.00K | £ 475.00K | £ 344.00K |
| Net Debt | £ -2.46M | £ -2.54M | £ -3.54M | £ -1.01M | £ -2.62M |
| Total Liabilities | £ 1.89M | £ 1.86M | £ 987.00K | £ 980.00K | £ 1.04M |
| Stockholders' Equity | £ 7.14M | £ 7.30M | £ 7.18M | £ 4.68M | £ 6.58M |
| Cash Flow | |||||
| Free Cash Flow | £ -298.00K | £ -281.00K | £ -1.38M | £ -1.62M | £ -3.27M |
| Operating Cash Flow | £ -137.00K | £ -219.00K | £ -1.33M | £ -1.17M | £ -2.36M |
| Investing Cash Flow | £ -59.00K | £ 70.00K | £ -85.00K | £ -449.00K | £ -904.00K |
| Financing Cash Flow | £ -459.00K | £ -196.00K | £ 3.89M | £ 132.00K | £ -66.00K |
RUA Life Sciences (DE:AOHA)
FRANKFURT:AOHA
